Season 1

COVID In Eyecare: Small Business Saturday

Jimmy and Roya meet with Josh Adams, vice President of Valley Contax, to discuss the effects of COVID on industry and how to adapt.

SOURCES 

Valley Contax https://www.valleycontax.com/

Boost Program https://www.valleycontax.com/boost-marketing/

Dry Eye Zone https://www.dryeyezone.com/

COVID In Eyecare: Masters Of Resuscitation

Jimmy and Roya have a discussion with Dr. Mark Wiseman about the ER perspective and outlook regarding COVID.

SOURCES 

https://www.cdc.gov

Hopkins Medicine COVID 19: https://www.hopkinsmedicine.org/coronavirus/

Dr Anthony Fauci: https://www.niaid.nih.gov/about/director

Dr Wise Guy: https://www.youtube.com/channel/UCklDVlFyxm_yGyNYstdiVHQ

Dr. Mark Wiseman’s Facebook: https://www.facebook.com/mark.wiseman.942

Who Codes? EyeCode!

Jimmy and Roya meet with guest Dr. Christopher Wolfe, for another amazing episode where you’ll learn more about EyeCode Education.

SOURCES  

Herschell Boyd https://topdoctorsusa.wordpress.com/2010/04/22/surgeons-gone-bad/

Visit Adherence and Visual Acuity: https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2760497

Valley Contax Boost Program: https://www.valleycontax.com/boost-marketing/

EyeCode Podcast: https://podcasts.apple.com/us/podcast/eyecode-media/id1449429774

Optometry 2018 Metrics: https://ecpu.com/media//wysiwyg/docs/ECPU_MBA_KeyMetricsReport_2018.pdf

Eye doctor tops malpractice settlement list: https://products.kitsapsun.com/archive/2000/06-30/0030_bellevue__eye_doctor_tops_malprac.html

Can AREDS Make Things Worse?

Jimmy and Roya meet with guest Greg Hines, to discuss age-related macular degeneration.

SOURCES:
Corona Virus Statement: HPI CoronaVirus Statement 1-30-20.pdf
Progression of Geographic Atrophy in ARMD: https://www.aaojournal.org/article/S0161-6420(18)30875-3/abstract
No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2
https://www.aaojournal.org/article/S0161-6420(18)32155-9/fulltext
CFH and ARMS2 genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementation. https://www.ncbi.nlm.nih.gov/pubmed/29311295
Response to AREDS supplements according to genetic factors: survival analysis approach using the eye as the unit of analysis. https://www.ncbi.nlm.nih.gov/pubmed/27471039
Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study. https://www.ncbi.nlm.nih.gov/pubmed/25200399

ArticDx: https://arcticdx.com/

Facebook
Instagram
Twitter